Stay updated on CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Sign up to get notified when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 appears in the study's history with a Study Status update. This indicates the record has been revised and the trial's status has been updated within the official history.
    Difference
    0.3%
    Check dated 2026-08-11T17:56:44.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The record history shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a small update to the page framework without impacting trial details.
    Difference
    0.1%
    Check dated 2026-07-21T12:52:46.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.3) was added to the history and the older tag (v3.6.0) was removed, reflecting an update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-06-30T02:15:28.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new revision (v3.6.0) adds a note that the study is no longer looking for participants. The previous revision label (v3.5.5) is removed from the history.
    Difference
    0.3%
    Check dated 2026-06-15T19:46:37.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    The page footer now displays revision v3.5.5 instead of v3.5.4, indicating a small update to the page's version.
    Difference
    0.1%
    Check dated 2026-06-08T17:15:13.000Z thumbnail image
  9. Check
    97 days ago
    Change Detected
    Summary
    The study record history now includes a new revision entry, v3.5.4, as the latest update. This new revision supersedes the previous v3.5.3 entry and signals a minor log update in the record history.
    Difference
    0.1%
    Check dated 2026-05-18T06:54:00.000Z thumbnail image

Stay in the know with updates to CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma

Enter your email address, and we'll notify you when there's something new on the CAMMA 2 Clinical Trial - Cevostamab in BCMA-Exposed Myeloma page.